BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Pfizer shakes up drug development staffing]]>http://www.bloggingstocks.com/2007/05/21/pfizer-shakes-up-drug-development-staffing/http://www.bloggingstocks.com/2007/05/21/pfizer-shakes-up-drug-development-staffing/http://www.bloggingstocks.com/2007/05/21/pfizer-shakes-up-drug-development-staffing/#commentsFiled under: , ,

The boomer generation is limping toward retirement with pockets full of cash and bodies full of ailments, putting any drug company with top-drawer medications and solid patents in line for a windfall. Today's shakeup at Pfizer's (NYSE: PFE) drug-pipeline management, with the announced retirement of R&D president John LaMattina [subscription required], suggests the company isn't happy with the lack of success in restocking its shelves.

Pfizer, the largest pharmaceutical company in the world, realized 64% of its 2006 revenue from its top nine sellers. Unfortunately, the patents for those brands are rapidly expiring:

  • Norvasc: 2007
  • Zyrtec: 2007
  • Lipitor: 2010
  • Viagra: 2012
  • Detrol: 2012
  • Cardura X: 2008

Continue reading Pfizer shakes up drug development staffing

Pfizer shakes up drug development staffing originally appeared on BloggingStocks on Mon, 21 May 2007 14:01:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments]]>carduradetroldrug companiesdrug companisDrugCompaniesDrugCompanisJeffrey KindlerJeffreyKindlerKindlerlijpitorMcMattinanorvascpfepfizerpharmaceuticalsviagrazyrtecMon, 21 May 2007 14:01:00 EST